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Summary Although primary cardiac amyloidosis is a rare afﬂiction of the heart, its
clinical and pathology features have been well described. Patients generally present
with exertional dyspnea, chest discomfort, or congestive heart failure. Cardiac imag-
ing typically reveals ventricular wall thickening, systolic and diastolic dysfunction,
valvular thickening, and pericardial effusion. In the case reported herein, a patient
with suspected cardiac amyloid demonstrated electrocardiographic and echocardio-
graphic ﬁndings that were not only inconsistent with typical depositional patterns,
but also potentially suggestive of endomyocardial disease.
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Introduction
Characteristics unique to classic cardiac amyloi-
dosis are well deﬁned in the literature and have
typical electrocardiographic (ECG) and imaging
features. However, the rare atypical variations,
due to unusual patterns of deposition, can be
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isconstrued as another form of restrictive car-
iomyopathy or over-looked altogether. This can
elay the diagnosis and treatment of cardiac amy-
oidosis.
ase reportlinical ﬁndings
n February 2004, a 54-year-old man was discov-
red to have a lambda light chain monoclonal
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 Echocardiographic images. (A) Apical four-
chamber transthoracic echocardiogram demonstrating a
thickened tricuspid valve (TV) and a rounded area of
thickening of the endocardial surface of the right atrium
(arrow). (B) Transesophageal view showing marked thick-
ening of the interatrial septum (IAS). RA, right atrium; RV,
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ammopathy on a routine blood work-up. At that
ime, bone marrow biopsy and aspirate were
erformed, and both were negative for amy-
oid deposition and for cytogenetic and myeloma
uorescent in situ hybridization (FISH) panel abnor-
alities. Bone marrow biopsy tissue showed 3—5%
lasma cells, which is normal. Computed tomogra-
hy scans of the chest, abdomen, and pelvis showed
o lymphadenopathy. Due to the apparent isolated
ature of the gammopathy, the patient had inter-
ittent follow-up.
Over the next 3 years he developed chronic
oarseness, which gastroenterology and ear, nose,
nd throat specialists attributed to gastroe-
ophageal reﬂux disease. He was subsequently
iagnosed with gastroparesis, and because of
is lambda light chain monoclonal gammopa-
hy, colonoscopy and esophagogastroduodenoscopy
ere performed on March 28, 2007. Small bowel
iopsy tissue showed amyloid involvement.
On June 18, 2007, the patient was referred to
he Mayo Clinic for further evaluation of amyloido-
is. He had a 5-month history of exertional dyspnea,
ith difﬁculty climbing stairs, as well as occasional
octurnal dyspnea and palpitations and one episode
f near-syncope that correlated with a stressful
onversation he had while driving. However, he
eported no episodes of actual syncope. There was
lso a 10-year history of well-controlled hyperten-
ion. An ECG showed normal sinus rhythm without
ow voltage. He did not undergo Holter monitor-
ng.
By trans-thoracic echocardiography, the left
entricle showed normal septal and free wall
hicknesses of 10mm each and normal dias-
olic and systolic chamber diameters of 40 and
3mm, respectively. Systolic function was nor-
al, with an ejection fraction of 70%. Later
hat day, the patient underwent trans-esophageal
chocardiography, which revealed similar ﬁndings.
n addition, both atria had mildly to moder-
tely thickened walls. Initially, neither study was
onsidered suggestive of inﬁltrative cardiomyopa-
hy.
However, review of the two echocardiograms
as performed and revealed increased right
entricular wall thickness with reduced systolic
unction and marked thickening of the atrial sep-
um. Additionally, thickening of the tricuspid and
ortic valves was noted (Fig. 1). The left ventri-
le was interpreted to have diastolic dysfunction
mitral E wave velocity = 0.8m/s, A wave = 0.3m/s,
eceleration time 180ms; medial annulus tis-
ue Doppler velocity = 0.04m/s, lateral = 0.03m/s;
edial E/e′ = 20, lateral E/e′ = 26; and pulmonary
ein velocity systolic = 0.2m/s, diastolic = 0.4m/s),
v
e
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wight ventricle; LA, left atrium; LV, left ventricle.
s well as possible mild apical non-compaction.
hese abnormalities were considered suggestive
f a restrictive process such as amyloidosis or
ven eosinophilic heart disease with endomyocar-
ial ﬁbrosis.
By cardiac magnetic resonance imaging (MRI),
he right ventricle exhibited increased wall thick-
ess and reduced systolic function with an ejection
raction of 36%. In addition, the atrial septum and
ricuspid valve apparatus were thickened, and the
ight ventricle showed a diffuse bright appearance
hyper-enhancement) rather than the usual pat-
ern of incomplete ‘‘nulling’’ of the myocardium
Fig. 2). Although the mechanism for this obser-
ation is unclear, we speculate that the primarily
ndocardial involvement in this patient may have
aused the appearance of hyper-enhancement.
onsidering the clinical scenario, the MRI ﬁndings
ere interpreted as suggestive of amyloidosis.
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Figure 2 Magnetic resonance images. (A) Steady-state
free acquisition image in a 4-chamber view in end-
diastole. Left ventricular thickness is normal. There is
a subtle increase in the thickness of the right ventricle,
tricuspid valve, and atrial walls. A small anterior pericar-
dial effusion is present. (B) Late gadolinium enhancement
image utilizing an inversion recovery fast gradient echo
sequence. There is late enhancement of the inferolat-
eral segment of the left ventricle (arrow), as well as very
prominent hyperenhancement of the entire right ventri-
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systolic dysfunction. Very rarely, cardiac amyloi-cle.
Consequently, a right ventricular endomyocar-
dial biopsy procedure was recommended for the
evaluation of possible cardiac involvement by
amyloidosis. During the cardiac catheterization
procedure, the following right-sided pressures were
recorded (in mmHg): right atrium 9, right ventri-
cle 37/0/8, pulmonary artery 31/11, and pulmonary
d
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apillary wedge pressure 16 (A-wave 21, and V-wave
6).
athology ﬁndings
ndomyocardial biopsy tissue from the septal sur-
ace of the right ventricle revealed amyloid in
hree of the four specimens (positive Congo red
nd sulfated Alcian blue stains), but in an unusual
istributional pattern. Focally, the endocardium
as moderately to markedly thickened by amy-
oid deposition, which formed prominent nodules
Fig. 3A and B). In contrast, the more typical
attern of pericellular interstitial deposition was
resent only to a mild degree. Vascular amyloid was
ild, but focally obstructive.
Immunohistochemical studies were performed
n parafﬁn sections using antibodies directed
gainst serum amyloid P component, kappa and
ambda immunoglobulin free light chains, prealbu-
in (transthyretin), and serum amyloid A. Amyloid
eposits stained positively for serum amyloid P
omponent and lambda light chains and negatively
or kappa light chains, prealbumin, and serum
myloid A (Fig. 3C and D). These ﬁndings were con-
idered consistent with the lambda light chain type
f primary amyloidosis.
iscussion
he current case is unique in its unusual pat-
ern of amyloid deposition which, in turn, led to
nusual ﬁndings by various cardiac imaging proce-
ures. These will be discussed, with an emphasis on
ndocardial and valvular amyloidosis and on similar
eatures that may be encountered with eosinophilic
ndomyocardial disease.
atterns of cardiac amyloidosis
myloid deposition occurs within the extracellu-
ar matrix of body tissues and organs. Because
f its stiff physical characteristics, deposition
ithin the myocardial interstitium is generally
ssociated with decreased compliance, restric-
ive hemodynamics, and diastolic dysfunction. Less
requently, small intramyocardial vessels may rep-
esent the primary site of amyloid deposition and
ay be associated with focal ischemia or regionalosis may show predominant deposition within
he valves or endocardium, resulting in valve
ysfunction or endocardial-based (non-myocardial)
estriction.
Endocardial amyloidosis 165
Figure 3 Microscopy of endomyocardial biopsy tissue. (A) Low-power view shows marked nodular deposition of amy-
loid along the endocardium (arrows) (hematoxylin—eosin). (B) Low-power view reveals strong staining of endocardial
amyloid deposits with Congo red (arrows). (C) Medium-power view demonstrates strong reactivity of endocardial amy-
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edium-power view shows negative immunohistochemica
ypical cardiac amyloidosis
atients with cardiac involvement by amyloidosis
ost commonly present with exertional dyspnea,
eakness, fatigue, chest discomfort, and often
vert congestive heart failure. Although the left
entricle typically shows appreciable wall thicken-
ng, the ECG often exhibits normal or low voltage,
onsistent with an interstitial inﬁltrative process
ather than myocyte hypertrophy. An echocardio-
raphic hallmark is the demonstration of diastolic
ysfunction [1,2]. Reduced systolic function may
lso be observed.hen to obtain a cardiac biopsy
f the presence of extracardiac amyloid has been
stablished, and if the patient has classic echocar-
iographic or cardiac MRI ﬁndings, then cardiac
c
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ubulin light chains, indicative of primary amyloidosis. (D)
ining for prealbumin (transthyretin).
nvolvement by amyloid may be presumed. In con-
rast, if a tissue diagnosis of amyloidosis has not
et been established, or if the clinical and imaging
ndings are not typical of cardiac amyloidosis, then
n endomyocardial biopsy procedure may be rec-
mmended to establish a deﬁnitive diagnosis. Not
o biopsy the heart in cases with atypical presenta-
ions may result in delayed diagnosis or in improper
reatment of the patient’s actual underlying amy-
oidosis.
nusual ﬁndings
n the present case, despite a history of mono-
lonal gammopathy and biopsy-proved existence of
astrointestinal amyloid, and in spite of a clinical
istory consistent with cardiac involvement, the
linical imaging studies were initially considered
ncharacteristic for myocardial amyloidosis. These
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showed only mild left ventricular diastolic dys-
function and possible apical non-compaction, right
ventricular wall thickening and diminished systolic
function, and thickened tricuspid and aortic valves.
Other features of this case were unlike typi-
cal amyloid as well, including an ECG that did not
show low voltage. Perhaps most deterring of all, the
echocardiographic studies showed normal left ven-
tricular free wall and septal thicknesses, without
typical ﬁndings of cardiac amyloidosis.
Clinicopathologic correlation
Once amyloid was identiﬁed in right ventricular
endomyocardial biopsy tissues, the reasons for the
unusual clinical ﬁndings became clear. Its depo-
sition was predominately endocardial, with little
myocardial involvement. This explains why left ven-
tricular thickness was within the normal range.
Endocardial deposition of amyloid also accounts for
thickening of the tricuspid and aortic valves and the
appearance suggestive of apical non-compaction.
Differential diagnosis
The imaging ﬁndings in this case also suggested
the possibility of eosinophilic endomyocardial dis-
ease. In most instances, this disorder affects the
ventricles with apical thrombus or endomyocardial
ﬁbrosis that may extend up to and interfere with
the atrioventricular valves and may cause heart
failure and chest pain [3,4]. The mild apical left
ventricular non-compaction in our patient, perhaps
accentuated by the endocardial amyloid, also had
[
[
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n appearance that could be misconstrued as mural
hrombus.
Moreover, this type of restrictive cardiomyopa-
hy can primarily affect the right ventricle and
reate a thickened and poorly compliant free wall,
s was seen in our patient [5]. Lastly, thickening
f the atrioventricular valves is another feature
f endomyocardial disease and could have corre-
ponded to the thickened tricuspid valve in the
resent case [6]. It was the history of amyloid
n non-cardiac tissues that lead to favoring of a
iagnosis of cardiac amyloidosis and subsequent
ndomyocardial biopsy in our patient.
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